FDA Drug Application (090252) for REPAGLINIDE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number090252
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameREPAGLINIDE
Active IngredientREPAGLINIDE

Active IngredientCount
List of drugs with Active Ingredient REPAGLINIDE4


Back to FDA Applications sponsored by MYLAN PHARMS INC